Baseline serum amino acid levels predict treatment response to augmentation with N-acetylcysteine (NAC) in a bipolar disorder randomised trial
- 1 October 2021
- journal article
- research article
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 142, 376-383
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- The chemistry and biological activities of N-acetylcysteineBiochimica et Biophysica Acta (BBA) - General Subjects, 2013
- Intake of Dairy Products, Calcium, Magnesium, and Phosphorus in Childhood and Age at Menarche in the Tehran Lipid and Glucose StudyPLOS ONE, 2013
- Maintenance N-acetyl cysteine treatment for bipolar disorder: A double-blind randomized placebo controlled trialBMC Medicine, 2012
- Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of conceptTranslational Psychiatry, 2011
- N-acetyl cysteine add-on treatment for bipolar II disorder: a subgroup analysis of a randomized placebo-controlled trialJournal of Affective Disorders, 2011
- Effects of N-acetyl-cysteine treatment on glutathione depletion and a short-term spatial memory deficit in 2-cyclohexene-1-one-treated ratsEuropean Journal of Pharmacology, 2010
- Response and remission criteria in major depression – A validation of current practiceJournal of Psychiatric Research, 2010
- N-Acetyl Cysteine for Depressive Symptoms in Bipolar Disorder—A Double-Blind Randomized Placebo-Controlled TrialBiological Psychiatry, 2008
- Amino acid requirements in inflammatory statesCanadian Journal of Animal Science, 2003
- Human Neutrophils Employ Myeloperoxidase To Convert α-Amino Acids to a Battery of Reactive Aldehydes: A Pathway for Aldehyde Generation at Sites of InflammationBiochemistry, 1998